Cyprotex - News
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Statement re: FSA

Cyprotex plc confirms that the Financial Services Authority (FSA) has discontinued its investigation into the Company and does not have any present intention to take further action in relation to Cyprotex.

For further information:

Mr John Nicholson, Chief Operating Officer
Cyprotex PLC

Tel: +44 (0) 1625 505 100
j.nicholson@cyprotex.com
www.cyprotex.com

Media enquiries:

Henry Harrison-Topham
Bankside Consultants Limited

Tel: +44 (0) 20 7444 4140
henry.ht@bankside.com
www.bankside.com

Contact us

News categories

Archives

Contact us to discuss your ADME Tox issues or request a quote

Telephone:
North America (East Coast): 888-297-7683
Europe: +44 1625 505100

 

or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

Close